Phase 4 trial in 306 adults with diabetic macular oedema: fluocinolone acetonide implant did not reduce rescue aflibercept injections vs aflibercept loading (mean 2.4 vs 2.5; P = 0.76). Cataract surgery 27.9% vs 6.6%; raised IOP 15.6% vs 3.3%.
RCTn = 306
Singer et al. Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study